Striatal glutamic acid decarboxylase immunoreactivity is increased after dopaminergic deafferentation: densitometric analysis

Neurosci Lett. 1991 Jan 28;122(2):252-6. doi: 10.1016/0304-3940(91)90871-p.

Abstract

Several lines of evidence suggest that dopamine exerts a chronic inhibitory action on GABAergic cells in the striatum, and striatal glutamic acid decarboxylase (GAD) mRNA levels are increased after ipsilateral dopaminergic denervation. In the present study we have used GAD immunocytochemistry to assess whether dopaminergic denervation results in an increase in GAD protein synthesis. In three 6-hydroxydopamine-lesioned animals, there was a perceptible increase in the density of GAD-immunoreactive (ir)staining on the side ipsilateral to the lesion. Computer-assisted densitometric analysis showed a significant increase in GAD-ir staining in the ipsilateral striatum compared to the contralateral (control) side. These data suggest that removal of striatal dopaminergic innervation results in an increase in the amount of immunoreactive GAD, the rate limiting enzyme in the synthesis of GABA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Afferent Pathways / drug effects
  • Afferent Pathways / physiology*
  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / enzymology*
  • Functional Laterality
  • Glutamate Decarboxylase / metabolism*
  • Hydroxydopamines / toxicity
  • Immunohistochemistry
  • Male
  • Organ Specificity
  • Oxidopamine
  • Parietal Lobe / drug effects
  • Parietal Lobe / enzymology
  • Rats
  • Rats, Inbred Strains
  • Reference Values
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Hydroxydopamines
  • Oxidopamine
  • Tyrosine 3-Monooxygenase
  • Glutamate Decarboxylase